Latest stories on PFE
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union | BNTX Stock News
StockTitan63 · neutralproduct/pr
CB&I CONTINUES GROWTH IN MIDDLE EAST WITH NEW ABU DHABI WELLS CONTRACT
PR Newswire50 · neutralgeneral
Pfizer shares may move 3% around Aug. 4 earnings release
Investing.com Markets56 · neutralearnings
Is Wall Street Bullish or Bearish on Pfizer Stock?
Barchart56 · neutralanalyst
Is Wall Street Bullish or Bearish on Pfizer Stock?
Barchart50 · neutralgeneral
Pfizer: Calling The Bottom - The Patent Cliff Is Real, But The Valuation Has Fallen Too Far
Seeking Alpha58 · neutralanalyst
Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.
Yahoo Top58 · neutralgeneral
Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.
The Motley Fool58 · neutralgeneral
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer
Yahoo Finance56 · neutralanalyst
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer
The Motley Fool56 · neutralanalyst
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029? - qz.com
Quartz55 · neutralgeneral
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029? - qz.com
Quartz63 · neutralanalyst
Pfizer Builds Oncology Growth Around Padcev and Pipeline Expansion - qz.com
Quartz63 · neutralproduct/pr
Pfizer Builds Oncology Growth Around Padcev and Pipeline Expansion - qz.com
Quartz63 · neutralproduct/pr
Pfizer gains priority review for Talzenna/Xtandi combo in prostate cancer
Seeking Alpha71 · bullishproduct/pr
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer | PFE Stock News
StockTitan73 · bullishproduct/pr
Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market?
The Motley Fool63 · neutralgeneral
SLS Stock Jumps Ahead Of CEO’s Fox Appearance: Retail Bets AML Readout Could Spark Big Pharma Bidding War
Stocktwits News63 · neutralgeneral
Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now
Yahoo Finance56 · neutralanalyst
Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now
The Motley Fool56 · neutralanalyst
Pfizer Paid Out $14.6 Billion in Dividends Over the Last 18 Months. Can It Keep This Up Through the Patent Cliff?
The Motley Fool42 · neutralgeneral
NCLA Urges Supreme Court to Hear Vaccine Mandate Case that Clearly Misreads Precedent
Business Insider50 · neutralgeneral
Dividend Roundup: JPMorgan Chase, Coca-Cola, Johnson & Johnson, Pfizer, and more
Seeking Alpha50 · neutralgeneral
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech
Seeking Alpha34 · bearishgeneral